159 related articles for article (PubMed ID: 36123608)
1. ANGPTL3 is involved in kidney injury in high-fat diet-fed mice by suppressing ACTN4 expression.
Li G; Lu D; Wang J; Yue S; Tan M; Liu M; Gao X
Lipids Health Dis; 2022 Sep; 21(1):90. PubMed ID: 36123608
[TBL] [Abstract][Full Text] [Related]
2. Angiopoietin-like protein 4 promotes hyperlipidemia-induced renal injury by down-regulating the expression of ACTN4.
Li Y; Gong W; Liu J; Chen X; Suo Y; Yang H; Gao X
Biochem Biophys Res Commun; 2022 Mar; 595():69-75. PubMed ID: 35101665
[TBL] [Abstract][Full Text] [Related]
3. ANGPTL4 promotes nephrotic syndrome by downregulating podocyte expression of ACTN4 and podocin.
Li Y; Xu Z; Deng H; Liu M; Lin X; Zhang M; Li G; Yue S; Gao X
Biochem Biophys Res Commun; 2023 Jan; 639():176-182. PubMed ID: 36495766
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-like protein 3 markedly enhanced in the hyperlipidemia related proteinuria.
Gao X; Suo Y; Zhang M; Wang Y; Gao X; Bing Q; Liu Q
Lipids Health Dis; 2019 May; 18(1):116. PubMed ID: 31103046
[TBL] [Abstract][Full Text] [Related]
5. Anti-proteinuria effect of antibody against ANGPTL3 coil-coiled domain on adriamycin-induced nephropathy in mice.
Han X; Dai R; Zhai Y; Shen Q; Sun L; Liu H; Xu H
Biochem Biophys Res Commun; 2019 Aug; 516(3):812-818. PubMed ID: 31256934
[TBL] [Abstract][Full Text] [Related]
6. Podocyte protection by Angptl3 knockout via inhibiting ROS/GRP78 pathway in LPS-induced acute kidney injury.
Ma Y; Liu J; Liu H; Han X; Sun L; Xu H
Int Immunopharmacol; 2022 Apr; 105():108549. PubMed ID: 35086056
[TBL] [Abstract][Full Text] [Related]
7. ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome.
Zhong F; Liu S; Li Y; Li G; Liu M; Wang J; Cui W; Suo Y; Gao X
Lipids Health Dis; 2022 Apr; 21(1):38. PubMed ID: 35399079
[TBL] [Abstract][Full Text] [Related]
8. Minnelide combined with Angptl3 knockout completely protects mice with adriamycin nephropathy via suppression of TGF-β1-Smad2 and p53 pathways.
Ji B; Liu J; Ma Y; Yin Y; Xu H; Shen Q; Yu J
Int Immunopharmacol; 2023 Feb; 115():109656. PubMed ID: 36608441
[TBL] [Abstract][Full Text] [Related]
9. Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage.
Lv Q; Han X; Ni J; Ma Q; Dai R; Liu J; Liu J; Zhai Y; Shen Q; Sun L; Liu H; Rao J; Xu H
Cell Death Dis; 2022 Oct; 13(10):867. PubMed ID: 36229446
[TBL] [Abstract][Full Text] [Related]
10. The Citrus Flavonoid Nobiletin Downregulates Angiopoietin-like Protein 3 (ANGPTL3) Expression and Exhibits Lipid-Modulating Effects in Hepatic Cells and Adult Zebrafish Models.
Lin CY; Chen PY; Hsu HJ; Gao WY; Wu MJ; Yen JH
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293338
[TBL] [Abstract][Full Text] [Related]
11. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis.
Asano T; Watanabe K; Kubota N; Gunji T; Omata M; Kadowaki T; Ohnishi S
J Gastroenterol Hepatol; 2009 Oct; 24(10):1669-76. PubMed ID: 19788607
[TBL] [Abstract][Full Text] [Related]
13. ANGPTL3 Deficiency and Risk of Hepatic Steatosis.
D'Erasmo L; Di Martino M; Neufeld T; Fraum TJ; Kang CJ; Burks KH; Di Costanzo A; Minicocci I; Bini S; Maranghi M; Pigna G; Labbadia G; Zheng J; Fierro D; Montali A; Ceci F; Catalano C; Davidson NO; Lucisano G; Nicolucci A; Arca M; Stitziel NO
Circulation; 2023 Nov; 148(19):1479-1489. PubMed ID: 37712257
[TBL] [Abstract][Full Text] [Related]
14. Undaria pinnatifida soluble fiber regulates Angptl3-LPL pathway to lessen hyperlipidemia in mice.
Xiao HB; Lu XY; Zhang HB; Sun ZL; Fang J
J Physiol Biochem; 2013 Dec; 69(4):719-25. PubMed ID: 23595961
[TBL] [Abstract][Full Text] [Related]
15. The relationship among nephrin, podocin, CD2AP, and alpha-actinin might not be a true 'interaction' in podocyte.
Fan Q; Xing Y; Ding J; Guan N; Zhang J
Kidney Int; 2006 Apr; 69(7):1207-15. PubMed ID: 16501493
[TBL] [Abstract][Full Text] [Related]
16. Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity.
Fujimoto K; Koishi R; Shimizugawa T; Ando Y
Exp Anim; 2006 Jan; 55(1):27-34. PubMed ID: 16508209
[TBL] [Abstract][Full Text] [Related]
17. A novel role of angiopoietin-like-3 associated with podocyte injury.
Liu J; Gao X; Zhai Y; Shen Q; Sun L; Feng C; Rao J; Liu H; Zha X; Guo M; Ma D; Zhang Z; Li R; Xu H
Pediatr Res; 2015 Jun; 77(6):732-9. PubMed ID: 25710887
[TBL] [Abstract][Full Text] [Related]
18. A novel fusion protein consisting of anti-ANGPTL3 antibody and interleukin-22 ameliorates diabetic nephropathy in mice.
Ma Q; Hu X; Liu F; Cao Z; Han L; Zhou K; Bai Y; Zhang Y; Nan Y; Lv Q; Rao J; Wu T; Yang X; He H; Ju D; Xu H
Front Immunol; 2022; 13():1011442. PubMed ID: 36544775
[TBL] [Abstract][Full Text] [Related]
19. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4.
Michaud JL; Lemieux LI; Dubé M; Vanderhyden BC; Robertson SJ; Kennedy CR
J Am Soc Nephrol; 2003 May; 14(5):1200-11. PubMed ID: 12707390
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-like protein 3 regulates the motility and permeability of podocytes by altering nephrin expression in vitro.
Gao X; Xu H; Liu H; Rao J; Li Y; Zha X
Biochem Biophys Res Commun; 2010 Aug; 399(1):31-6. PubMed ID: 20633534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]